Antihypertensives Market Size, Share, Growth Rate, Global Industry Report 2032

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Antihypertensives Market, 2024-2032 (USD Billion)
  • 2.2. Antihypertensives Market: Snapshot
• Chapter 3. Antihypertensives Market - Industry Analysis
  • 3.1. Antihypertensives Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Driver 1
    • 3.2.2. Driver 2
  • 3.3. Restraints
    • 3.3.1. Restraint 1
    • 3.3.2. Restraint 2
  • 3.4. Opportunity
    • 3.4.1. Government funding and support
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis By Product
    • 3.6.2. Market attractiveness analysis by Region
• Chapter 4. Antihypertensives Market- Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global Antihypertensives Market: company market share, 2024
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New Product launches
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and Regional expansion
  • 4.3. Price trend analysis
• Chapter 5. Global Antihypertensives Market -Product Analysis
  • 5.1. Global Antihypertensives Market overview: By Drug Class
    • 5.1.1. Global Antihypertensives Market share, By Product,2024 and 2032
  • 5.2. Diuretics
    • 5.2.1. Global Antihypertensives Market by Diuretics, 2024-2032 (USD Billion)
  • 5.3. Angiotensin receptor blockers (ARBs)
    • 5.3.1. Global Antihypertensives Marketby Angiotensin receptor blockers (ARBs), 2024-2032 (USD Billion)
  • 5.4. Angiotensin converting enzyme (ACE) inhibitors
    • 5.4.1. Global Antihypertensives Market by Angiotensin converting enzyme (ACE) inhibitors, 2024-2032 (USD Billion)
  • 5.5. Beta blockers
    • 5.5.1. Global Antihypertensives Market by Beta blockers, 2024-2032 (USD Billion)
  • 5.6. Alpha blockers
    • 5.6.1. Global Antihypertensives Market by Alpha blockers, 2024-2032 (USD Billion)
  • 5.7. Calcium channel blockers
    • 5.7.1. Global Antihypertensives Market by Calcium channel blockers, 2024-2032 (USD Billion)
  • 5.8. Renin inhibitors
    • 5.8.1. Global Antihypertensives Market by Renin inhibitors, 2024-2032 (USD Billion)
  • 5.9. Vasodilators
    • 5.9.1. Global Antihypertensives Market by Vasodilators, 2024-2032 (USD Billion)
  • 5.10. Other Drugs
    • 5.10.1. Global Antihypertensives Market by Other Drugs, 2024-2032 (USD Billion)
• Chapter 6. Global Antihypertensives Market - Regional Analysis
  • 6.1. Global Antihypertensives Market overview: by Region
    • 6.1.1. Global Antihypertensives Marketshare, by Region, 2024 and 2032
  • 6.2. North America
    • 6.2.1. North America Antihypertensives Market, 2024-2032 (USD Billion)
    • 6.2.2. North America Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.2.3. The U.S.
      • 6.2.3.1. The U.S.Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.2.4. Rest of North America
      • 6.2.4.1. Rest of North America Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Antihypertensives Market, 2024-2032 (USD Billion)
    • 6.3.2. Europe Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.3.3. UK
      • 6.3.3.1. U.K.Antihypertensives Marketrevenue, By Product,2024-2032 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. France Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.3.5. Germany
      • 6.3.5.1. Germany Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.3.6. Rest of Europe
      • 6.3.6.1. Rest of Europe Antihypertensives Marketrevenue, By Product,2024-2032 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Antihypertensives Market, 2024-2032 (USD Billion)
    • 6.4.2. Asia Pacific Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.4.3. China
      • 6.4.3.1. China Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.4.4. Japan
      • 6.4.4.1. Japan Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.4.5. India
      • 6.4.5.1. India Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.4.6. Rest of Asia Pacific
      • 6.4.6.1. Rest of Asia Pacific Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Antihypertensives Market, 2024-2032 (USD Billion)
    • 6.5.2. Latin America Antihypertensives Market revenue, By Product,2024-2032 (USD Billion)
    • 6.5.3. Brazil
      • 6.5.3.1. Brazil Antihypertensives Marketrevenue, By Product,2024-2032 (USD Billion)
    • 6.5.4. Rest of LatinAmerica
      • 6.5.4.1. Rest of LatinAmerica Antihypertensives Marketrevenue, By Product,2024-2032 (USD Billion)
  • 6.6. The Middle East and Africa
    • 6.6.1. The Middle East and Africa Antihypertensives Market, 2024-2032 (USD Billion)
    • 6.6.2. The Middle East and Africa Antihypertensives Marketrevenue, By Product,2024-2032 (USD Billion)
• Chapter 7. Company Profiles
  • 7.1. AstraZeneca Plc
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Johnson & Johnson Ltd
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Lupin Limited
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. Boehringer Ingelheim
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Merck & Co.
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Development
  • 7.6. Sanofi S.A.
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Development
  • 7.7. Novartis AG
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Development
  • 7.8. Pfizer Inc.
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Development
  • 7.9. Daiichi Sankyo Company Limited
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global antihypertensives market, 2024-2032 (USD Billion)
4. Porter’s five forces analysis: antihypertensives market
5. Global antihypertensives market attractiveness, by drug class
6. Global antihypertensives market revenue share, by drug class, 2024 and 2032
7. Global antihypertensives market by Diuretics, 2024-2032 (USD Billion)
8. Global antihypertensives market by Angiotensin receptor blockers (ARBs), 2024-2032 (USD Billion)
9. Global antihypertensives market by Angiotensin converting enzyme (ACE) inhibitors, 2024-2032 (USD Billion)
10. Global antihypertensives market by Beta blockers, 2024-2032 (USD Billion)
11. Global antihypertensives market by Alpha blockers, 2024-2032 (USD Billion)
12. Global antihypertensives market by Calcium channel blockers, 2024-2032 (USD Billion)
13. Global antihypertensives market by Renin inhibitors, 2024-2032 (USD Billion)
14. Global antihypertensives market by Vasodilators, 2024-2032 (USD Billion)
15. Global antihypertensives market by Other Drugs, 2024-2032 (USD Billion)
16. Global antihypertensives market revenue share, by region, 2024 & 2032
17. North America antihypertensives market, 2024-2032 (USD Billion)
18. Europe antihypertensives market, 2024-2032 (USD Billion)
19. Asia Pacific antihypertensives market, 2024-2032 (USD Billion)
20. Latin America antihypertensives market, 2024-2032 (USD Billion)
21. Middle East & Africa antihypertensives market, 2024-2032 (USD Billion)

Table Of Tables

List of Tables

1. Global antihypertensives market: snapshot
2. Drivers for antihypertensives market: impact analysis
3. Restraints for antihypertensives market: impact analysis
4. North America antihypertensives market revenue, by country, 2024-2032 (USD Billion)
5. North America antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
6. The U.S. antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
7. Rest of North America antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
8. Europe antihypertensives market revenue, by country, 2024-2032 (USD Billion)
9. Europe antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
10. U.K. antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
11. France antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
12. Germany antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
13. Rest of Europe antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
14. Asia Pacific antihypertensives market revenue, by country, 2024-2032 (USD Billion)
15. Asia Pacific antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
16. China antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
17. Japan antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
18. India antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
19. Rest of Asia Pacific antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
20. Latin America antihypertensives market revenue, by country, 2024-2032 (USD Billion)
21. Latin America antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
22. Brazil antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
23. Rest of Latin America antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)
24. Middle  East & Africa antihypertensives market revenue, by drug class, 2024-2032 (USD Billion)